The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,961
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712 · cited 3×
“Most recently, the tumour suppressor ARID1A has been shown to be mutated in almost half of CCC cases [28,29].”
BackgroundSelf-citationNovel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467
Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., Redman, B. G., Margolin, K. A., Merchan, J. R., Wilding, G., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2516 · Cited by 1,230
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
Piccart, M. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.699 · Cited by 981
Mutation of the PIK3CA Gene in Ovarian and Breast Cancer
Campbell, I. G., Russell, S. E., Choong, D. Y. H., Montgomery, K. G., Ciavarella, M. L., Hooi, C. S. F., Cristiano, B. E., Pearson, R. B., & Phillips, W. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2933 · Cited by 916
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
Self-citationSugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I., & Taguchi, K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2584::aid-cncr22>3.0.co;2-5 · Cited by 795
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ahmed, A. A., Etemadmoghadam, D., Temple, J., Lynch, A. G., Riad, M., Sharma, R., Stewart, C., Fereday, S., Caldas, C., deFazio, A., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2696 · Cited by 787
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
Trimbos, J. B., Vergote, I., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.113 · Cited by 674
Vasey, P. A., Jayson, G. C., Gordon, A., Gabra, H., Coleman, R., Atkinson, R., Parkin, D., Paul, J., Hay, A., Kaye, S. B., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh323 · Cited by 632
Vergote, I., De Brabanter, J., Fyles, A., Bertelsen, K., Einhorn, N., Sevelda, P., Gore, M. E., Kærn, J., Verrelst, H., Sjövall, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03590-x · Cited by 623
The SWI/SNF complex and cancer
Reisman, D., Glaros, S., & Thompson, E. A. (2009) · Oncogene · doi:10.1038/onc.2009.4 · Cited by 568
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 547
Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
Yap, T. A., Garrett, M. D., Walton, M. I., Raynaud, F., de Bono, J. S., & Workman, P. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.004 · Cited by 543
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuo, K.-T., Mao, T.-L., Jones, S., Veras, E., Ayhan, A., Wang, T.-L., Glas, R., Slamon, D., Velculescu, V. E., Kuman, R. J., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081000 · Cited by 485
du Bois, A., Quinn, M., Thigpen, T., Vermorken, J., Avall-Lundqvist, E., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi961 · Cited by 465
Chan, J. K., Teoh, D., Hu, J. M., Shin, J. Y., Osann, K., & Kapp, D. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.02.006 · Cited by 450
The genesis and evolution of high-grade serous ovarian cancer
Bowtell, D. D. L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2946 · Cited by 445
(ICON1), I. C. O. N. 1., & European Organisation for Research and Treatment of Cancer Collaborators–Adjuvant ChemoTherapy In Ovarian Neoplasm (EORTC–ACTION) (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.105 · Cited by 443
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Köbel, M., Kalloger, S. E., Huntsman, D. G., Santos, J. L., Swenerton, K. D., Seidman, J. D., & Gilks, C. B. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181c042b6 · Cited by 398
Self-citationPPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
Lu, X., Nannenga, B., & Donehower, L. A. (2005) · Genes & Development · doi:10.1101/gad.1291305 · Cited by 389
Zorn, K. K., Bonome, T., Gangi, L., Chandramouli, G. V. R., Awtrey, C. S., Gardner, G. J., Barrett, J. C., Boyd, J., & Birrer, M. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0508 · Cited by 376
Goff, B. A., Sainz de la Cuesta, R., Muntz, H. G., Fleischhacker, D., Ek, M., Rice, L. W., Nikrui, N., Tamimi, H. K., Cain, J. M., Greer, B. E., et al. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0065 · Cited by 352
Kobayashi, H., Sumimoto, K., Moniwa, N., Imai, M., Takakura, K., Kuromaki, T., Morioka, E., Arisawa, K., & Terao, T. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00754.x · Cited by 305
Mackay, H. J., Brady, M. F., Oza, A. M., Reuss, A., Pujade-Lauraine, E., Swart, A. M., Siddiqui, N., Colombo, N., Bookman, M. A., Pfisterer, J., et al. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181dd0110 · Cited by 271
Self-citationTakano, M., Kikuchi, Y., Yaegashi, N., Kuzuya, K., Ueki, M., Tsuda, H., Suzuki, M., Kigawa, J., Takeuchi, S., Tsuda, H., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603116 · Cited by 266
Gilks, C. B., Ionescu, D. N., Kalloger, S. E., Köbel, M., Irving, J., Clarke, B., Santos, J., Le, N., Moravan, V., & Swenerton, K. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.01.003 · Cited by 242
Self-citationJiang, Z., Chu, P. G., Woda, B. A., Rock, K. L., Liu, Q., Hsieh, C.-C., Li, C., Chen, W., Duan, H. O., McDougal, S., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70732-x · Cited by 242
Huang, D., Ding, Y., Li, Y., Luo, W.-M., Zhang, Z.-F., Snider, J., VandenBeldt, K., Qian, C.-N., & Teh, B. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3722 · Cited by 240
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
Itamochi, H., Kigawa, J., & Terakawa, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00747.x · Cited by 237
Köbel, M., Kalloger, S. E., Carrick, J., Huntsman, D., Asad, H., Oliva, E., Ewanowich, C. A., Soslow, R. A., & Gilks, C. B. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181788546 · Cited by 231
Self-citationWang, F.-S., Wang, C.-J., Chen, Y.-J., Chang, P.-R., Huang, Y.-T., Sun, Y.-C., Huang, H.-C., Yang, Y.-J., & Yang, K. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308013200 · Cited by 229
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
Kumar, R., Crouthamel, M.-C., Rominger, D. H., Gontarek, R. R., Tummino, P. J., Levin, R. A., & King, A. G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605366 · Cited by 218
Pectasides, D., Fountzilas, G., Aravantinos, G., Kalofonos, H. P., Efstathiou, E., Salamalekis, E., Farmakis, D., Skarlos, D., Briasoulis, E., Economopoulos, T., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.056 · Cited by 215
Tothill, R. W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., van Laar, R. K., Waring, P. M., Zalcberg, J., Ward, R., Biankin, A. V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3617 · Cited by 215
Racial and ethnic disparities in benign gynecologic conditions and associated surgeries
Jacoby, V. L., Fujimoto, V. Y., Giudice, L. C., Kuppermann, M., & Washington, A. E. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.039 · Cited by 213
Satoh, T., Hatae, M., Watanabe, Y., Yaegashi, N., Ishiko, O., Kodama, S., Yamaguchi, S., Ochiai, K., Takano, M., Yokota, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.8617 · Cited by 211
Pfisterer, J., Weber, B., Reuss, A., Kimmig, R., du Bois, A., Wagner, U., Bourgeois, H., Meier, W., Costa, S., Blohmer, J.-U., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj296 · Cited by 211
du Bois, A., Weber, B., Rochon, J., Meier, W., Goupil, A., Olbricht, S., Barats, J.-C., Kuhn, W., Orfeuvre, H., Wagner, U., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2938 · Cited by 196
Ovarian tumors associated with atypical endometriosis
LaGrenade, A., & Silverberg, S. G. (1988) · Human Pathology · doi:10.1016/s0046-8177(88)80090-x · Cited by 195
HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint
Kawabe, T., Muslin, A. J., & Korsmeyer, S. J. (1997) · Nature · doi:10.1038/385454a0 · Cited by 193
Yamaguchi, K., Mandai, M., Oura, T., Matsumura, N., Hamanishi, J., Baba, T., Matsui, S., Murphy, S. K., & Konishi, I. (2010) · Oncogene · doi:10.1038/onc.2009.470 · Cited by 184
Ovarian clear cell adenocarcinoma
Kennedy, A. W., Biscotti, C. V., Hart, W. R., & Webster, K. D. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90637-9 · Cited by 178
The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomas
Köbel, M., Reuss, A., Bois, A. D., Kommoss, S., Kommoss, F., Gao, D., Kalloger, S. E., Huntsman, D. G., & Gilks, C. B. (2010) · The Journal of Pathology · doi:10.1002/path.2744 · Cited by 170
Self-citationHirasawa, A., Saito-Ohara, F., Inoue, J., Aoki, D., Susumu, N., Yokoyama, A., Nozawa, S., Inazawa, J., & Imoto, I. (2003) · PubMed · Cited by 166
PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
Tan, D. S. P., Lambros, M. B. K., Rayter, S., Natrajan, R., Vatcheva, R., Gao, Q., Marchiò, C., Geyer, F. C., Savage, K., Parry, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2403 · Cited by 164
Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study
Köbel, M., Kalloger, S. E., Baker, P. M., Ewanowich, C. A., Arseneau, J., Zherebitskiy, V. A., Abdulkarim, S., Leung, S. C. Y., Duggan, M. A., Fontaine, D., et al. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e1a3bb · Cited by 156
Self-citationNagl, N. G., Patsialou, A., Haines, D. S., Dallas, P. B., Beck, G. R., & Morán, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1225 · Cited by 145
Anglesio, M. S., Arnold, J. M., George, J., Tinker, A. V., Tothill, R. W., Waddell, N., Simms, L. A., Locandro, B., Fereday, S., Traficante, N., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0193 · Cited by 144
Self-citationA histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes.
Czernobilsky, B., & Morris, W. J. (1979) · PubMed · Cited by 143
Köbel, M., Xu, H., Bourne, P. A., Spaulding, B. O., Shih, I., Mao, T., Soslow, R. A., Ewanowich, C. A., Kalloger, S. E., Mehl, E., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.206 · Cited by 143
Self-citationPectasides, D. G., Fountzilas, G., Aravantinos, G., Kalofonos, C. P., Efstathiou, H., Farmakis, D. T., Skarlos, D., Pavlidis, N., Economopoulos, T., & Dimopoulos, M. A. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.12.038 · Cited by 141
Leu, J. I., Crissey, M. A. S., Leu, J. P., Ciliberto, G., & Taub, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.414-424.2001 · Cited by 134 · cited 4×
“This pathway appears to involve IL-6 and STAT3 converging on HNF1B [50], the hypoxia induced transcription factors HIF1A and EPAS1 [[49], Anglesio et al., in press, and Michael Birrer, personal communication].”
BackgroundInfluentialKöbel, M., Kalloger, S. E., Santos, J. L., Huntsman, D. D., Gilks, C. B., & Swenerton, K. D. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.09.029 · Cited by 133
Self-citationPrognostic implication of endometriosis in clear cell carcinoma of the ovary
Orezzoli, J. P., Russell, A. H., Oliva, E., Carmen, M. G. D., Eichhorn, J., & Fuller, A. F. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.025 · Cited by 127
Duska, L., Garrett, L. A., Henretta, M. S., Ferriss, J. S., Lee, L. K., & Horowitz, N. S. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.069 · Cited by 127
Salani, R., Kurman, R. J., Giuntoli, R. L., Gardner, G. J., Bristow, R. E., Wang, T., & Shih, I. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01039.x · Cited by 120
Nagl, N. G., Zweitzig, D. R., Thimmapaya, B., Beck, G. R., & Morán, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3427 · Cited by 120
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)
Kobayashi (2009) · Oncology Reports · doi:10.3892/or_00000429 · Cited by 115
Aris, A. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-2 · Cited by 112
Calculator for ovarian carcinoma subtype prediction
Kalloger, S. E., Köbel, M., Leung, S. C. Y., Mehl, E., Gao, D., Marcon, K. M., Chow, C., Clarke, B. A., Huntsman, D. D., & Gilks, C. B. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.215 · Cited by 111
Self-citationImplication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene
Giraud, S., Hurlstone, A. F. L., Avril, S., & Coqueret, O. (2004) · Oncogene · doi:10.1038/sj.onc.1207972 · Cited by 105
Ho, C., Huang, R. Y., Chen, T.-C., Huang, S., Liu, F.-S., Chien, C.-C. C., Yu, M.-H., Mao, T., Wang, T., & Hsieh, C. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.04.004 · Cited by 102
Body size and ovarian cancer: case–control study and systematic review (Australia)
Purdie, D. M., Bain, C. J., Webb, P. M., Whiteman, D. C., Pirozzo, S., & Green, A. C. (2001) · Cancer Causes & Control · doi:10.1023/a:1012267619561 · Cited by 100
Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women
Riman, T., Dickman, P. W., Nilsson, S., Nordlinder, H., Magnusson, C., & Persson, I. R. (2004) · European Journal of Epidemiology · doi:10.1007/s10654-004-1633-8 · Cited by 100
Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary
Mizuno, M., Kikkawa, F., Shibata, K., Kajiyama, H., Ino, K., Kawai, M., Nagasaka, T., & Nomura, S. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20251 · Cited by 95
Takano, M., Sugiyama, T., Yaegashi, N., Sakuma, M., Suzuki, M., Saga, Y., Kuzuya, K., Kigawa, J., Shimada, M., Tsuda, H., et al. (2008) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01158.x · Cited by 95
Why do Kinase Inhibitors Cause Cardiotoxicity and What can be Done About It?
Cheng, H., & Force, T. L. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.06.006 · Cited by 90
Han, G., Gilks, C. B., Leung, S. C. Y., Ewanowich, C. A., Irving, J. A., Longacre, T. A., & Soslow, R. A. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318164edf7 · Cited by 89
Suzuki, S., Kajiyama, H., Shibata, K., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn059 · Cited by 89
Yoo, C., Kim, J. E., Lee, J.-L., Ahn, J. H., Lee, D. H., Js, L., Na, S., Kim, C.-S., Hong, J. H., Hong, B., et al. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq073 · Cited by 86
PTEN expression in clear cell adenocarcinoma of the ovary
Hashiguchi, Y., Tsuda, H., Inoue, T., Berkowitz, R. S., & Mok, S. C. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.09.047 · Cited by 86
Suehiro, Y., Sakamoto, M., Umayahara, K., Iwabuchi, H., Sakamoto, H., Tanaka, N., Takeshima, N., Yamauchi, K., Hasumi, K., Akiya, T., et al. (2000) · Oncology · doi:10.1159/000012137 · Cited by 77
Therapeutic strategy targeting the mTOR–HIF‐1α–VEGF pathway in ovarian clear cell adenocarcinoma
Miyazawa, M., Yasuda, M., Fujita, M., Kajiwara, H., Hirabayashi, K., Takekoshi, S., Hirasawa, T., Murakami, M., Ogane, N., Kiguchi, K., et al. (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02320.x · Cited by 76
Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma
Lee, S., Garner, E. I. O., Welch, W. R., Berkowitz, R. S., & Mok, S. C. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.03.041 · Cited by 75
Endometriosis: candidate genes
Campbell, I., & Thomas, E. J. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.1.15 · Cited by 74
Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers
Swenerton, K. D., Santos, J. L., Gilks, C. B., Köbel, M., Hoskins, P. J., Wong, F., & Le, N. D. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq383 · Cited by 66
Self-citationYan, Y., Cao, P. T., Greer, P. M., Nagengast, E. S., Kolb, R. H., Mumby, M. C., & Cowan, K. H. (2010) · Oncogene · doi:10.1038/onc.2010.187 · Cited by 65
Utsunomiya, H., Akahira, J., TANNO, S., Moriya, T., Toyoshima, M., Niikura, H., Ito, K., Morimura, Y., Watanabe, Y., & Yaegashi, N. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00289.x · Cited by 62
Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary
Nagai, Y., Inamine, M., Hirakawa, M., Kamiyama, K., Ogawa, K., Toita, T., Murayama, S., & Aoki, Y. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.079 · Cited by 61
Clear Cell Carcinoma Compared to Serous Carcinoma in Early Ovarian Cancer
Timmers, P. J., Zwinderman, A. H., Teodorovic, I., Vergote, I. B., & Trimbos, J. B. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181991546 · Cited by 59
Body size and risk of epithelial ovarian and related cancers: A population‐based case‐control study
Olsen, C. M., Nagle, C. M., Whiteman, D. C., Purdie, D. M., Green, A. C., & Webb, P. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23509 · Cited by 57
Takakura, S., Takano, M., Takahashi, F., et al. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181cafb47 · Cited by 57
Clear-cell cancer of the ovary?is it chemosensitive?
Pather, S., & Quinn, M. A. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.15305.x · Cited by 51
The Impact of Complete Surgical Staging Upon Survival in Early-Stage Ovarian Clear Cell Carcinoma
Takano, M., Sugiyama, T., Yaegashi, N., et al. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a83f4f · Cited by 44
Anthropometry and the risk of epithelial ovarian cancer
Greer, J. B., Modugno, F., Ness, R. B., & Allen, G. O. (2006) · Cancer · doi:10.1002/cncr.21830 · Cited by 40
Effects of treatment by temsirolimus on patients with clear cell carcinoma of the ovary.
Kikuchi, Y., Kudoh, K., Takano, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.5086 · Cited by 5
Cited by
Ovarian Cancer: A Heterogeneous Disease
Kossaï, M., Leary, A., Scoazec, J.-Y., & Genestie, C. (2018) · Pathobiology · doi:10.1159/000479006 · Cited by 388
Use of mutation profiles to refine the classification of endometrial carcinomas
McConechy, M. K., Ding, J., Cheang, M. C., Wiegand, K. C., Senz, J., Tone, A. A., Yang, W., Prentice, L. M., Tse, K., Zeng, T., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4056 · Cited by 301
Self-citationMcAlpine, J. N., Hanley, G. E., Woo, M. M. M., Tone, A. A., Rozenberg, N., Swenerton, K. D., Gilks, C. B., Finlayson, S. J., Huntsman, D. G., & Miller, D. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.003 · Cited by 286
Self-citationGenomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Wang, Y. K., Bashashati, A., Anglesio, M. S., Cochrane, D. R., Grewal, D. S., Ha, G., McPherson, A., Horlings, H. M., Senz, J., Prentice, L. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3849 · Cited by 273
Self-citationType-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
Anglesio, M. S., Wiegand, K. C., Melnyk, N., Chow, C., Salamanca, C., Prentice, L. M., Senz, J., Yang, W., Spillman, M. A., Cochrane, D. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072162 · Cited by 253
Self-citation
Metadata
- Authors
- Anglesio, M. S., Carey, M. S., Köbel, M., MacKay, H., & Huntsman, D. G.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 121
- Issue
- 2
- Pages
- 407-415
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2064330422
- Cited by
- 272
- References
- 96
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.